
Ivadac 7.5mg Tablet
Marketer
Ikon Remedies Pvt Ltd
Salt Composition
Ivabradine (7.5mg)
Overview Ivadac 7.5mg Tablet
Cardoxin 7.5mg tablets effectively manage angina pectoris (chest pain stemming from heart issues) and persistent heart failure. Its mechanism involves optimizing cardiac function by reducing heart rate, thereby mitigating chest discomfort and minimizing hospital readmissions for heart failure. Dosage is individualized based on the specific condition. Given the typically lifelong nature of angina and heart failure treatment, discontinuation should only occur under medical supervision. Consistent daily ingestion with meals is recommended. Overdose may cause excessive bradycardia (slow heart rate), fatigue, and shortness of breath; seek immediate medical counsel if this occurs. Common, albeit usually transient, adverse effects encompass visual disturbances, bradycardia, hypertension, atrial fibrillation, lightheadedness, blurred vision, and electrocardiographic alterations. Serious side effects like syncope (fainting) and significant arrhythmias necessitate prompt medical attention. Refrain from driving until the drug's effects are known. Contraindications include severe hepatic impairment, resting bradycardia, cardiac arrhythmias, severely low blood pressure, and recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Uses of Ivadac 7.5mg Tablet
Managing angina pectoris (chest pain due to heart ischemia) and heart failure.
Major Benefits of Ivadac 7.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Ivadac 7.5mg Tablet with a meal.
Common Side effects of Ivadac 7.5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivadac 7.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ivadac 7.5mg Tablet should be administered with food.
How Ivadac 7.5mg Tablet works:
Ivadac 7.5mg tablets decrease cardiac rate, thereby diminishing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivadac 7.5mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyUNSAFE
The use of Ivadac 7.5mg tablets is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in both animal models and pregnant women indicates substantial risks to the fetus.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Ivadac 7.5mg Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivadac 7.5mg Tablet, a medication that can induce temporary visual disturbances, primarily phosphenes. The potential for these light flashes should be considered, particularly during nighttime driving.
KidneyCAUTION
Patients with severe kidney impairment should use Ivadac 7.5mg Tablets cautiously, as dose modification may be necessary. A physician's consultation is recommended. Data regarding Ivadac 7.5mg Tablet use in this patient population is limited.
LiverCAUTION
Patients with liver impairment should use Ivadac 7.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Ivadac 7.5mg tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Ivadac 7.5mg Tablet :
Omit any missed Ivadac 7.5mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ivadac 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzazepine compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Sodium channel blockers targeting the sinoatrial node |
